Follow this link for the full text
Date of publication: 23 January 2012
Publication type: Guideline
In a nutshell: NICE recommends apixaban as a possible treatment to reduce the risk of venous thromboembolism in adults. It is recommended because it works more effectively and costs less than one of the most commonly used drugs available on the NHS that is used to reduce the risk of thromboembolism. apixaban should be given shortly after surgery and for a few weeks after this to prevent VTE.
Length of publication: 42 pages
Some important notes: Please contact your local NHS library if you cannot access the full text. Follow this link to find your local NHS library.